Is Biomx Inc (PHGE) overvalued? · P/E 0.0, rev $332.0K
Biomx Inc (PHGE) is a biotechnology company listed on US.
This page asks whether Biomx Inc (PHGE) looks expensive on cached numbers — not a short thesis.
Latest reported PHGE revenue for 2026-06-30 was $332.0K. Net income was -$3.8M. PHGE currently screens at market cap $11.5M and trailing P/E 0.0.
PHGE currently screens at market cap $11.5M and trailing P/E 0.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PHGE 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PHGE stock page for the full model, not this heading.
Not investment advice.